← Leaderboards
Seok-Yong Lee
Duke University
$17,896,850
Attributed
$23,075,932
Total exposure
11
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.5M · FY2011–25$5M$3.8M$2.5M$1.3M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$23,075,932 · 11
By mechanism
R01$10,878,005 · 6
R35$7,839,417 · 2
DP2$2,355,000 · 1
R61$1,563,778 · 1
R21$439,732 · 1
Top collaborators
- Jiyong Hong12 shared
- Ru-Rong Ji5 shared
- Kenichi Yokoyama4 shared
Most similar at Duke University
Same institution · by research overlap
- Kenichi Yokoyama$7,433,719
- Jiyong Hong$5,518,476
Others in their field
Top investigators on “Structure”
- David Heimbrook · Leidos Biomedical Research, Inc.$475,333,582
- Barton F Haynes · Duke University$444,977,767
- Lawrence Corey · Fred Hutchinson Cancer Center$334,646,086
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$315,257,203
Research focus
StructureMolecularDesignFuturePharmacologyComplexPainMembraneInsightNeuronsPropertyCellsBindingMolecular ConformationExhibitsCell MembraneNucleosidesTherapeutic DevelopmentChronic PainMembrane Transport ProteinsBaseSignal TransductionNovel TherapeuticsAnalog
Grant awards (44)
Catalysis and inhibition of chitin synthesis from pathogenic fungi$1,216,954
R01 · FY2025 · AI
Structure, function, and pharmacology of sensory receptors$885,128
R35 · FY2025 · NS · contact PI
TRPM8 in eye health and disease$471,291
R01 · FY2025 · EY · contact PI
Developing equilibrative nucleoside transporter inhibitors as non-opioid pain therapeutics$1,563,778
R61 · FY2024 · NS · contact PI
Structure, function, and pharmacology of sensory receptors$885,128
R35 · FY2024 · NS · contact PI
Catalysis and inhibition of chitin synthesis from pathogenic fungi$613,629
R01 · FY2024 · AI
TRPM8 in eye health and disease$477,235
R01 · FY2024 · EY · contact PI
Structure, function, and pharmacology of neuronal membrane transport proteins$790,724
R35 · FY2023 · NS · contact PI
Catalysis and inhibition of chitin synthesis from pathogenic fungi$611,375
R01 · FY2023 · AI
TRPM8 in eye health and disease$409,999
R01 · FY2023 · EY · contact PI
Molecular basis of adenosine transport and reuptake inhibition in human$406,553
R01 · FY2023 · GM · contact PI
Molecular principles of anti-COVID-19 drug uptake by human nucleoside transporters$199,712
R21 · FY2023 · AI · contact PI
Structure, function, and pharmacology of neuronal membrane transport proteins$790,724
R35 · FY2022 · NS · contact PI
Catalysis and inhibition of chitin synthesis from pathogenic fungi$639,109
R01 · FY2022 · AI
Molecular basis of adenosine transport and reuptake inhibition in human$406,553
R01 · FY2022 · GM · contact PI
TRPM8 in eye health and disease$397,697
R01 · FY2022 · EY · contact PI
Molecular principles of anti-COVID-19 drug uptake by human nucleoside transporters$240,020
R21 · FY2022 · AI · contact PI
Structure, function, and pharmacology of neuronal membrane transport proteins$790,724
R35 · FY2021 · NS · contact PI
Molecular basis of adenosine transport and reuptake inhibition in human$406,553
R01 · FY2021 · GM · contact PI
TRPM8 in eye health and disease$397,699
R01 · FY2021 · EY · contact PI
Structure, function, and pharmacology of neuronal membrane transport proteins$112,694
R35 · FY2021 · NS · contact PI
Molecular basis of adenosine transport and reuptake inhibition in human$35,589
R01 · FY2021 · GM · contact PI
Structure, function, and pharmacology of neuronal membrane transport proteins$28,175
R35 · FY2021 · NS · contact PI
Structure, function, and pharmacology of neuronal membrane transport proteins$711,224
R35 · FY2020 · NS · contact PI
TRPM8 in eye health and disease$412,754
R01 · FY2020 · EY · contact PI
Molecular basis of adenosine transport and reuptake inhibition in human$406,553
R01 · FY2020 · GM · contact PI
Structural and Mechanistic Characterization of MraY Catalysis and Inhibition$342,648
R01 · FY2020 · GM · contact PI
Structure, function, and pharmacology of neuronal membrane transport proteins$711,224
R35 · FY2019 · NS · contact PI
Structural and Mechanistic Characterization of MraY Catalysis and Inhibition$342,648
R01 · FY2019 · GM · contact PI
Structure, function, and pharmacology of neuronal membrane transport proteins$711,224
R35 · FY2018 · NS · contact PI
Structural and Mechanistic Characterization of MraY Catalysis and Inhibition$342,648
R01 · FY2018 · GM · contact PI
Structure, function, and pharmacology of neuronal membrane transport proteins$711,224
R35 · FY2017 · NS · contact PI
Structural and Mechanistic Characterization of MraY Catalysis and Inhibition$342,648
R01 · FY2017 · GM · contact PI
Development of novel therapeutics for pain and itch relief$159,000
R01 · FY2017 · NS · contact PI
Structure, function, and pharmacology of neuronal membrane transport proteins$711,224
R35 · FY2016 · NS · contact PI
Structure and Function of Concentrative Nucleoside Transporters$294,088
R01 · FY2016 · GM · contact PI
Development of novel therapeutics for pain and itch relief$172,250
R01 · FY2016 · NS · contact PI
Development of novel therapeutics for pain and itch relief$318,000
R01 · FY2015 · NS · contact PI
Structure and Function of Concentrative Nucleoside Transporters$294,170
R01 · FY2015 · GM · contact PI
Structure and Function of Concentrative Nucleoside Transporters$57,437
R01 · FY2015 · GM · contact PI
Development of novel therapeutics for pain and itch relief$314,334
R01 · FY2014 · NS · contact PI
Structure and Function of Concentrative Nucleoside Transporters$294,251
R01 · FY2014 · GM · contact PI
Structure and Function of Concentrative Nucleoside Transporters$294,340
R01 · FY2013 · GM · contact PI
Pharmacology and biophysics of the voltage-gated sodium channel Nav1.7: a therape$2,355,000
DP2 · FY2011 · OD · contact PI